Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. - Kelsen,D.; Karpeh,M.; Schwartz,G. (J Clin Oncol, 1996)